Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostate
- 1 August 1985
- Vol. 26 (2) , 117-124
- https://doi.org/10.1016/0090-4295(85)90042-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- New prostate cancer drugs: few CV effects?Published by American Medical Association (AMA) ,1983
- THERAPEUTIC POTENTIAL OF THE LHRH AGONIST, ICI 118630, IN THE TREATMENT OF ADVANCED PROSTATIC CARCINOMAThe Lancet, 1983
- TREATMENT OF ADVANCED PROSTATIC CANCER WITH LHRH ANALOGUE ICI 118630: CLINICAL RESPONSE AND HORMONAL MECHANISMSThe Lancet, 1983
- The Treatment of Metastatic Prostatic Cancer With A Potent Luteinizing Hormone Releasing Hormone AnalogueJournal of Urology, 1983
- Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.Journal of Clinical Investigation, 1983
- Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.BMJ, 1983
- The Effect of the Chronic Administration of a Potent Luteinizing Hormone Releasing Hormone Analog on the Rat ProstateJournal of Urology, 1982
- Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult menFertility and Sterility, 1982
- Gonadotropin-Releasing Hormone Analogues for Prostate Cancer: Untoward Side Effects of High-Dose Regimens Acquire a Therapeutical DimensionEuropean Urology, 1982
- LH‐RH Agonists and AntagonistsInternational Journal of Gynecology & Obstetrics, 1980